Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT07111559

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07111559
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07111559. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2028-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
Acronym
LACUNAR-tPA
Condition
Lacunar Stroke
Condition
Stroke
Intervention (Drug)
rt-PA
Intervention (Drug)
DAPT
Lead sponsor
Nippon Medical School (class: other)
Collaborator
Japan Research Foundation for Clinical Pharmacology (class: not stated)
Collaborator
Takeda Science Foundation - Medical Research Grant (class: not stated)

Record details

Record id
cardio:ct-nct07111559
Content hash
ecbba76576a455ac0a5499bef083b4006ee5065147f598d14b824a73f44e741a